Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Breast 1

Conditions

Polycystic Ovary Syndrome 2Obesity 2Stress, Psychological 1Sexual Dysfunction, Physiological 1Pain 1Overweight 1Hematopoietic and Lymphoid System Neoplasm 1Health Education 1Fatigue 1Depression 1Cognitive Dysfunction 1Anxiety Disorders 1

Interventions

alvimopan 3Ketamine 2oxycodone naloxone combination 1naloxegol 1aluminum hydroxide, magnesium hydroxide, drug combination 1Xylitol 1Radiotherapy 1Quality of Life 1Oxycodone 1Nicotine 1Neck Dissection 1Naloxone 1Mindfulness-Based Stress Reduction 1Lidocaine 1Injections 1Gelclair 1Fibroblast Growth Factor 7 1Exercise Movement Techniques 1Doxepin 1Diphenhydramine 1Cisplatin 1Betaine 1Aromatherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain × Mindfulness-Based Stress Reduction × Other × Clear all
NCT02518308 2019-11-15

Mindfulness Intervention in Reducing Anxiety in Patients Who Have Been Treated for Gynecologic Cancer

University of Wisconsin, Madison

Phase NA Completed
38 enrolled
Other

Anxiety Disorders, Depression, Fatigue, Pain, Sexual Dysfunction, Physiological, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡